CNS Pharmaceuticals, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for CNS Pharmaceuticals, Inc. (CNSP) is -0.19

According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.19. This represents a change of -23.02% compared to the average of -0.25 of the last 4 quarters.

CNS Pharmaceuticals, Inc. (CNSP) Historical PE Ratio (quarterly & annually)

How has CNSP PE Ratio performed in the past?

The mean historical PE Ratio of CNS Pharmaceuticals, Inc. over the last ten years is -41.66. The current -0.19 PE Ratio has changed -54.39% with respect to the historical average. Over the past ten years (40 quarters), CNSP's PE Ratio was at its highest in in the March 2022 quarter at -0.03. The PE Ratio was at its lowest in in the September 2018 quarter at -97.32.

CNS Pharmaceuticals, Inc. (CNSP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CNS Pharmaceuticals, Inc. (CNSP) Average PE Ratio

How has CNSP PE Ratio performed in the past?

The current PE Ratio of CNS Pharmaceuticals, Inc. (CNSP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CNS Pharmaceuticals, Inc. (CNSP) PE Ratio vs. Peers

How is CNSP’s PE Ratio compared to its peers?

CNS Pharmaceuticals, Inc.’s PE Ratio is less than Windtree Therapeutics, Inc. (-0.00), greater than Pasithea Therapeutics Corp. (-0.21), greater than NLS Pharmaceutics AG (-0.61), greater than Soligenix, Inc. (-0.20), less than Oragenics, Inc. (-0.09), less than 60 Degrees Pharmaceuticals, Inc. (-0.16), greater than Clearmind Medicine Inc. (-0.27), less than Ensysce Biosciences, Inc. (-0.08), less than GRI Bio, Inc. (-0.02), greater than Silo Pharma, Inc. (-0.82),

Build a custom stock screener for CNS Pharmaceuticals, Inc. (CNSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNS Pharmaceuticals, Inc. (CNSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.